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ABSTRACT: Exposure to carcinogenic chemicals, Helicobacter pylori infection, and
high dietary salt are the risk factors associated with gastric cancer. Mice models of
gastric cancer are key to understanding the cancer mechanism, to discerning the role
played by different factors, and to determining therapeutic effects of different
treatments. The goal has been to find targets which are only expressed with cancer so
that they can be targeted specifically without harming normal cells. One such target
could be the transferrin receptor, a glycoprotein receptor that is expressed many-folds
on rapidly growing cells due to the greater demand of iron. In this study, gastric cancer
was developed in mice (BALB/c) with human cancer-associated risk factors by feeding
them with tumor-inducing concentration of methyl nitrosourea, dietary salt, and H.
pylori along with normal feed and water. Three strategies were adopted to induce gastric
cancer; (1) use of N-methyl-N-nitrosourea (MNU) with high dietary salt (NaCl), (2)
infection with H. pylori (isolated from human gastric tissue), and (3) use of MNU along
with high concentration of NaCl after H. pylori infection. Mice were dissected after
induction, and histological study of gastric tissue was done with Hematoxylin and Eosin staining. A diagnostic probe comprising
transferrin conjugated with cadmium sulfide quantum dots was prepared and characterized. It was used to study the transferrin
receptor overexpression in gastric tissue of cancer-induced mice relative to the normal mice. Mice of group 3 showed the highest rate
of the cancer incidence ratio (96%) along with a high expression of transferrin receptors among the three groups. Histochemical
studies showed that different types of gastric cancer depend upon the cancer-induction conditions. The mouse model of group 3 has
the potential to be used in the future to study the therapeutic effects of cancer medicines, and overexpression of transferrin receptors
could be identified through the designed probe to be used as diagnostics.
1. INTRODUCTION
Among all dreadful diseases, cancer is the foremost cause of
death around the world, and its incidence is increasing
worldwide. Gastric cancer is its most prevalent type worldwide
with high mortality, causing around one million deaths
worldwide.1 In Asia, it is the second most common cause of
death,2 and to detect it early is the only way to reduce the
mortality and burden of the disease. Gastric carcinoma may be
due to many factors such as carcinogenic chemicals including
high salt intake, organic solvents, insecticides, pesticides,
microbial infections, e.g., Helicobacter pylori,3 and occurrence
of certain mutations.4 In all the cases, it appears to originate
from the lining of the stomach. The expression of transferrin
receptors increases many-folds on cancer cells as compared to
normal cells.5,6 This positive correlation7 can be justified due
to the high iron demand of rapidly growing cells.8,9 This
relationship makes the transferrin receptor an important target
for drug delivery of nanomedicines either through transferrin
protein10,11 or using antitransferrin receptor antibodies.12 Such
targeted drug delivery can potentially avoid the toxic effects on
normal cells and allow for a limited concentration of drug to be
released in a controlled manner.13
Animal models enhance our understanding of various
cancers at the molecular level and also help us to check the
therapeutic effects of newly designed drugs prior to human
trials.14,15 In this study, a mouse model is established to study
the effects of H. pylori, chemical carcinogens (N-methyl-N′-
nitro-N-nitrosoguanidine (MNNG) and N-methyl-N-nitro-
sourea (MNU)), or by using the combination of both
chemicals and microbes in the induction of gastric cancer.
BALB/c mice were used to develop the gastric cancer model as
they have a very well characterized disease pathology. The
particular strain has established reticular, lung, and renal
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tumors but has been shown to be resistant to develop colon
cancer.16,17 Therefore, a proper strategy is required to develop
the BALB/c gastric cancer model.
H. pylori has a significant effect on stomach pathogenesis and
etiology. The need for an animal model to understand human
gastritis and cancer is strongly reflected in the literature.18
Studies have reported different levels of gastric pathology in
different animal species with prolonged H. pylori infection.15
Similarly, animal models of chemical carcinogenesis are
developed to study the effect of different chemicals in gastric
pathology. Compounds containing nitroso functional groups
such as nitroso amines, e.g., MNNG and MNU are considered
to be an important gastric cancer-inducing agent in humans
(generated by anaerobic bacteria19). However, lack of chronic
inflammation (caused by H. pylori infection) in chemically
induced gastric cancers have been a drawback of such models.
Therefore, in this study we have combined both factors to have
a more realistic model of the actual disease.19 This model will
have applications in studying the therapeutic effects of new
medicines. This study is designed for the early detection of
cancer by probing the transferrin receptor overexpression. For
this, we have used transferring-coated cadmium sulfide
quantum dots (QDs), which have myriad applications in
biosciences due to their unique optical, electronic, and thermal
properties. They have a high energy band gap and their surface
chemistry can easily be manipulated by capping with useful
functional groups and linkers, which can act as stabilizing
agents and can be used for conjugation with ligands and
medicines.20,21 Effects and induction levels of the mentioned
cancer-causing agents were correlated with relative expression
of transferrin receptors on gastric tissue in order to probe the
cancerous tissue for the potential future treatment.
2. RESULTS AND DISCUSSION
Mice models are reliable for studying the exposure effects of
different cancer-associated risk factors for various cancers and
allow us to design and test therapeutics against them.15 A
number of procedures have been adopted to induce gastric
cancer in mice including the exposure to MNU, high dietary
salt concentration, prolonged infection with H. pylori, and
genetically induced gastric cancer.15,22 The main objective of
the study is to find targeted sites of rapidly dividing cells in the
mouse model of gastric cancer by probing transferrin receptors,
expression of which was examined in affected gastric tissues of
all mice groups with different pathological severities. In order
to get an effective response from the mouse model that closely
showed the human gastric cancer physiology, three cancer-
induction methods were designed as described in the Section
4. The long-term exposure with carcinogenic chemicals and H.
pylori for cancer induction has increased the cancer incidence
ratio with discernible stomach pathology. This study is not
only useful to establish a successful gastric cancer model in
BALB/c mice but also useful to correlate the transferrin
receptor expression with cancer pathology. Future application
of this work includes the use of the modified QDs and nano/
microparticles as a vehicle for drug delivery to cancer cells.
2.1. Group 1(MNU and NaCl-Induced Cancer). A total
of 50 mice (25 males/25 females) were housed under this
group, 20 mice for a 6 month study and 30 mice for 12
months. One male in the 6 month group died after 3 weeks
and was excluded from the study. After 26 weeks of exposure
to MNU + NaCl cancer induction, 19 mice were dissected. In
the 12 month induction group, five mice died before 40 weeks
and therefore were excluded from the study (total 25) while
two mice died after 45 weeks but were retained in the study.
Mice were dissected at predetermined times and blood and
Figure 1.Macroscopic examination of the stomach of groups 1, 2, and 3 mice. Gross anatomical studies of the infected stomach show inflammation
and protruded masses at the stomach outer surfaces with severe infection in group 1 and 2 mice (a and e). The opened stomach (from the lesser
curvature) shows a change in color due to hemorrhage with an uneven surface, inflammation, lesions, abscesses and a number of small polyps (b
and c), and severe changes in morphology with abnormal surfaces (d). Open stomach examinations of group 2 mice show uneven surfaces, change
in coloration, abscess, inflammation, lesion, and polypoid masses, indicated by arrows (f, g, and h). The gross anatomy of the group 3 mouse
stomach with abnormal surface pathology, protruded masses, change in color, tumor, and inflammation (i). The morphological study of the group 3
mouse open stomach shows a change in coloration, abscess, inflammation, lesions (j), tumor masses and a severely affected surface (k), and
sarcoma in polyps (l).
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stomach samples were collected for serology, histology, and
immunohistochemical studies. The average initial weight of the
animals was 20 ± 2 g and a gradual gain of weight was
observed up to 15 weeks. After 15 weeks animals showed
variation in gaining weight according to the level of severity of
affected stomach tissues. After 40 weeks of inoculation, mice
became lethargic and started to lose weight.
The gross anatomy of the stomach was observed, and it
showed that the stomach lining was uneven with lesions and
abscesses. Several small polyp masses were observed in mice
treated with MNU and high diet salt for 6 months. Surface
morphology of the mouse group after 12 months was more
severe, showing abnormal surface pathology with protruded
masses, uneven surface, hemorrhage, inflammation, abscesses,
polyps, and small tumors (Figure 1a−d).
Histological examination (after 6 months) (Figure 2a,b)
showed severe gastritis, atrophy, and in some cases dysplasia
along with inflammatory response, invasive carcinoma, and
adenocarcinoma. Epithelial layer erosion, epithelial cell
abnormalities, hypertrophy, and hyperplasia with fusion of
the cells were the most common conditions prevailing in this
group. Cross-section studies showed that most of the animal’s
tissue had polypoidal dysplastic lesions, hemorrhage, neoplastic
lesion, influx of inflammatory cells in whole stomach tissue,
and mucinous abnormalities.
Histological study (after 12 months) showed severe
inflammation with influx of neutrophils and monocytes in
mucus cells and the mucinous layer. Inflammation also resulted
in the loss of parietal cells that led to dysplasia in some cases
(Figure 2c). Histological sections reveal spindle cells with
marked atypia, hyperchromasia, and malignant gastrointestinal
tumor (GIST) as shown in Figure 2e. The study also revealed
the presence of a mixed type of cancer in mice like polypoidal
with signet ring cell carcinoma (Figure 2d), adenocarcinoma
with signet rings, and diffused carcinoma with signet ring cell
carcinoma. Most of the histological sections showed the
dysplastic changes with the influx of inflammatory cells and the
presence of giant cells and tumor cells (Figure 2f). Different
forms and stages of cancer cells were studied, like tumor
desmoplasia with invasive adenocarcinoma (Figure 2i), well
differentiated adenocarcinoma (Figure 2g), and moderately
differentiated (Figure 2h) and poorly differentiated tumor
carcinoma.
Table 1 shows the gastric pathology and incidence of gastric
cancer that is 36% after 6 months and 68% after 12 months of
treatment for cancer induction based on histological study
results in group 1. Inflammation and abscess were observed in
100% mice. Induced cancer included gastrointestinal stromal
cell carcinoma, signet ring cell carcinoma, polypoidal
adenocarcinoma, and neuroendocrine gastric tumor carcinoma.
Group 1 results are in agreement with the previously
published studies in different animal species and in different
mouse species, though the cancer/inflammation incident rate
is different.3 N-Methyl-N-nitrosourea (MNU) was also used to
promote gastric carcinogenesis in wild-type (wt) and cdh1+/−
mice and reported 75% tumor incidence in the selected
species.23
2.2. Group 2 (H. pylori-Induced Cancer). H. pylori is
Gram-negative bacteria that colonize the gastric epithelial cells
and infect almost half of the world population. Gastric H. pylori
infection causes “the gastric ulceration”24 and, prolonged
colonization leads site-specific diseases including dreadful
gastric cancer.25,26 Human gastric biopsy samples were
collected with known history of infection and inflammation.
H. pylori was harvested from the gastric biopsy sample,
cultivated, harvested, and characterized by invasive, non-
invasive, and molecular techniques.
Figure 2. MNU+ high salt diet-induced gastric carcinoma (H&E 40×). After 6 months: Photomicrographs show (a) tumor desmoplasia with
invasive adenocarcinoma and mucinous infiltration with inflammatory cells. (b) Neoplastic lesion with carcinoma in situ and superficial atypia.
After 12 months: Photomicrographs show (c) hyperplasic conditions with dysplastic changes and fusion of cells. (d) Mixed type of carcinoma
polypoidal with signet ring cell carcinoma (indicated by arrows). (e) Morphological changes in gastric tissue due to GIST. Histological sections
reveal spindle cells with marked atypia, hyperchromasia, and malignant gastrointestinal tumor. (f) Adenocarcinoma with the presence of giant
tumor cells. (g) Well-differentiated adenocarcinoma, (h) moderately differentiated adenocarcinoma with mucosal infiltration of inflammatory cells,
and (i) tumor desmoplasia with invasive adenocarcinoma and mucinous infiltration with inflammatory cells.
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A group of 45 mice were housed in this group, where 25
mice were examined after 6 months while the remaining 20
after 12 months. Five mice died after 5 days of inoculation
through oral gavages and were excluded from the study. Five
new males were infected and added in the group to balance the
number of animals in the 6 month time frame group. Four
mice died after 47 weeks and their stomach were fixed and
included in the 12 month group. Initial average weight was 20
± 2.0 g, and no regular pattern of weight gain was observed.
The weight of the animal was seen to depend on the severity of
infection, and the maximum weight was found to be 34.0 ± 4.0
g and the minimum was 30.0 ± 2.0 g at the end of 6 months.
After 6 months, few animals showed little increase in weight
while others presented a weight loss, and the average weight at
the time of dissection was 30.0 ± 3.0 g, except for two mice
with significant tumors, pushing the average weight to 35 g.
After selected time frames of inoculation, mice were dissected,
blood was collected for serology, and the stomach for histology
studies.
Gross anatomy study of the stomach showed an uneven
surface with lesions at 6 months and abscess and protruded
masses after 12 months (Figure 1e). Macroscopic studies
showed the change in tissue morphology, abscess, hemorrhage,
inflammation, and polypoid masses that turned in to severe
pathological conditions and small polyp tumors (Figure 1f−h).
Histological study of H. pylori infected mice for 6 months
showed irregular-shaped follicular glands with hypertrophy,
hyperplasia, epithelial abnormalities, fusion of cells, severe
gastritis, atrophy, and in some cases metaplasia and dysplasia
along with inflammatory response (Figure 3a−c). Inflamma-
tion also resulted in the loss of parietal cells that led to
metaplasia and dysplasia in some mice. Epithelial abnormalities
were also observed on histological sections such as erosion on
the mucosal outer layer and severe architectural abnormalities
of mucosal cells, inflammation, and cytoplasmic abnormalities
due to atrophy. Polypoidal arrangement with dysplastic
Table 1. Gross Anatomy and Histopathological Findings of
the Stomach after 6 and 12 Months of Study in Groups 1, 2,
and 3a
group 1 group 2 group 3
findings 6 m 12 m 6 m 12 m 6 m 12 m
total number of animals 20 30 25 20 30 30
dead during infection 1 5 5 4 7 11
cancer incidence
percentage
36% 68% 25% 55% 65% 96%
uneven surface and
hemorrhage
10 25 4 16 17 24
presence of
inflammatory cells
17 25 20 16 23 24
mucosal and submucosal
abscess
19 25 15 16 23 24
GIST 0 2 0 1 3 5
signet ring cell
carcinoma
0 3 0 1 1 3
polypoid
adenocarcinoma
1 2 0 0 3 6
metaplasia 0 0 3 4 2 5
dysplasia 4 3 2 5 8 10
sarcoma 0 1 0 0 0 2
adenocarcinoma 2 7 0 1 4 8
lymphoma 0 0 0 2 0 2
mixed carcinoma 1 4 0 2 2 10
aSome mice showed mixed carcinoma; therefore, they are counted in
more than one column of the existing cancer type.
Figure 3. H. pylori-induced gastric carcinoma. Photomicrograph (H&E) reveals epithelial abnormalities, metaplasia, and adenocarcinoma. After 6
months: photomicrographs show (a) adenocarcinoma with abnormalities in parietal cells with variation in nucleus size, shape, number per cells, and
fusion of cells, (b) complete metaplasia with epithelial abnormalities, and (c) adenocarcinoma with incomplete metaplasia, cell fusion, and
structural abnormalities. After 12 months: photomicrographs show (d) morphological changes in gastric tissue due to GIST, (e) complete
metaplasia with the influx of inflammatory cells and severe epithelial abnormalities, (f) invasive adenocarcinoma, (g) well differentiated
adenocarcinoma, and (h,i) non-Hodgkin mantle cell lymphoma (histological sections show irregular nucleus distribution with the presence of pink
histocytes).
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changes and adenocarcinoma having variation in nucleus size,
shape, and number per cells were also observed in some cases.
Two mice had adenocarcinoma with incomplete metaplasia,
cell fusion, and structural abnormalities. All mice gave H. pylori
positive results from the stomach at the time of dissection.
Histological sections of most of the mice after 12 months of
infection demonstrated the presence of giant tumor cells and
their fusion. Mice in this group suffered with carcinoma having
variation in nucleus size, shape, and number per cells. GIST
(Figure 3d) and polypoid adenocarcinoma were also observed
in members of this group. A rare case of non-Hodgkin mantle
lymphoma was also observed in two cases (Figure 3h,i).
Complete metaplasia, which is the most common pathological
condition associated with H. pylori, was also observed with the
influx of inflammatory cells (Figure 3e) and epithelial
abnormalities in induced gastric carcinoma after 12 months
of infection. Invasive carcinoma (Figure 3f) and well
differentiated (Figure 3g) and high-grade adenocarcinoma
were also observed.
Table 1 shows the gastric pathology and incidence of gastric
cancers in group 2 based on results of histological study (25%
after 6 months and 55% after 12 months). At 12 months,
almost all animals showed an influx of inflammatory cells and
different types of pathological conditions including mixed
types of carcinomas, metaplasia, and dysplasia.
H. pylori always counts as an associated reason for gastritis,
and prolong gastritis leads to stomach cancer. H. pylori
induction models not only help to study the host−microbe
interaction but also provides insight into the mechanism of
inflammatory carcinomas.27 Group 2 results are in agreement
of previously published data of cancer induction by H. pylori
with different incidence rates in different rodents.28,29
2.3. Group 3 (MNU + NaCl + H. pylori-Induced
Cancer). MNU is an established chemical carcinogen to
develop gastric cancer in an animal model,15 with one
limitation that models developed a lack of chronic inflamma-
tory response and stomach pathology caused by H. pylori
infections. In this research, therefore, a combination of H.
pylori infection and MNU is used to get high incidence of
gastric cancer as previously tested in Mongolian gerbils.19
A total of 60 mice were housed under this group, 30 were
dissected and observed after 6 months and 30 after 12 months.
A total of seven mice including three male and four female
mice died before 20 weeks and were excluded from the study.
Mice were kept under complete observation and their weight
was measured on a regular basis. The initial average weight was
20.0 ± 2.0 g, and there was no specific pattern of weight gain in
mice of this group. The average weight at the time of
dissection was 26.0 ± 2.0 g at 6 months and 35.0 ± 3.0 g at 12
months. After the selected time frames, mice were dissected,
blood was collected for serology, and stomach for histology
and immunohistochemical studies.
Gross anatomy of the mouse stomach showed abnormal
surface pathology with protruded masses, tumors, and
inflammation. Surface morphology study showed an uneven
surface, hemorrhage, inflammation, abscess, polyp, and small
tumors (Figure 1i). Macroscopic examination showed uneven
surfaces with lesion, abscess, forestomach sarcoma, several
internal small polyp masses, and tumors (Figure 1j−l).
Histological study (after 6 months) showed severe gastritis,
atrophy, dysplasia along with inflammatory response, invasive
carcinoma, GIST, polypoidal, signet ring cell carcinoma,
metaplasia, squamous cell carcinoma, and adenocarcinoma.
Microscopic studies of histological sections showed greater
incidence of cancer than groups 1 and 2 with increased
severity. Most of the histological studies showed a mixed type
of cancer occurrence like polypoidal with signet ring cell
carcinoma (Figure 4b). The histological section showed the
influx of inflammatory cells in a mucus layer and moderately
differentiated carcinoma (Figure 4e), poorly differentiated
carcinoma (Figure 4d), diffused adenocarcinoma, GIST with
spindles cells (Figure 4a), GIST with tumor necrotic cells
(Figure 4c), and squamous cell carcinoma (Figure 4f).
Histological studies after 12 months showed severe
inflammation of mucosa-associated lymphoid tissue (MALT)
with the influx of neutrophils and monocytes in mucus cells
and mucinous layers. Inflammation also resulted in the loss of
parietal cells that led to dysplasia and adenocarcinoma.
Microscopic studies revealed the presence of high-grade
carcinoma of different types such as neuroendocrine carcinoma
(Figure 5e,f), GIST with tumor nests (Figure 5a), signet ring
Figure 4. H. pylori + MNU + high salt diet-induced gastric carcinoma (after 6 months). The photomicrograph (H&E 40×) (a) reveals the
morphological changes in gastric tissue due to GIST. Histological sections reveal spindle cells with marked atypia, hyperchromasia, and malignant
gastrointestinal tumor, (b) represents the morphological changes due to the polypoidal carcinoma and formation of rings (indicated by arrows) due
to signet ring cell carcinoma, (c) reveals GIST malignant gastrointestinal tumor with necrotic cells, (d) presents the poorly differentiated
adenocarcinoma, (e) demonstrates high grade moderately differentiated carcinoma, and (f) reveals the morphological changes and the presence of
squamous cell carcinoma.
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cell carcinoma, squamous cell carcinoma (Figure 5b), necrotic
tumor cells along with the lymphatic cells (Figure 5i),
metaplasia, high-grade adenocarcinoma (Figure 5g), poorly
differentiated adenocarcinoma (Figure 5c,h), and tumors
(Figure 5d,i) including non-Hodgkin lymphoma. Severity of
cancer in this group enhanced many-folds and showed to
spread to all the layers of the stomach. Figure 5a shows
invasive carcinoma’s spread to the submucosa and muscular
layer with tumor nests floating. Table 1 shows the gastric
pathology and incidence of gastric cancers that is 65% in group
3 after 6 months and 96% after 12 months, on the basis of
histological study results. Inflammation was observed in most
of the mice, and abscesses were seen in all the mice. Figure 6
shows the schematic presentation of cancer incidence and
types of gastric cancer in group 3 after 12 months.
Cancer induction in group 3 (H. pylori + MNU + high
dietary NaCl) showed the tremendous increase in the
incidence of cancer (Figure 6). Histological studies showed
existence of different forms of cancer with a high grade and
severe abnormalities in cellular morphology. Most of the
cancers were poorly differentiated carcinoma with greater
incidence and severity in this group as compared to others
even after 6 months. Herein, results clearly demonstrate that
mouse models can be developed in a shorter time period by
using the combination of H. pylori infection, chemical
carcinogens (MNU), and effect-enhancing risk factors such
as high concentration of NaCl. The severe stomach pathology
conditions were observed in this group alongside of hallmarks
of inflammation closer to the actual disease. The combination
strategy of cancer induction is also reported in C57BL/6 J
mice and scientists claimed a 100% cancer incidence rate in
this species.30 In another study, the cancer incidence rate in
C57BL/6 J mice with MNU and H. pylori was 68.8%.31
2.4. Targeted Diagnostic Probe Preparation and
Characterization. QD nanoparticle size is very important
for their optical properties and their applications as a biological
marker. Surface chemistry can easily be studied through
employing Fourier transform infrared (FTIR) spectroscopy
and ensuring that surface chemistry has changed successfully
after conjugation with linkers and the labels.20 The schematic
model of cysteine-capped CdS QDs in Figure 7a,b shows the
model of the targeted diagnostic probe after the conjugation of
the transferrin protein amine group with the carboxylic group
of cysteine. Modified QDs were characterized before
conjugation (reported in the previous study with size below
7 nm14) and after conjugation with transferrin protein. Size of
nanocomposites was analyzed by dynamic light scattering
Figure 5. MNU+ high salt diet + H. pylori-induced gastric carcinoma (after 12 months). Photomicrographs (H&E) taken at 40× (a−d,f,g,h),10×
(e), and 20× (i). (a) shows spread of carcinoma to submucosa (with floating tumor cell nests) and invasive adenocarcinoma. (b) shows squamous
cell carcinoma. (c) shows poorly differentiated adenocarcinoma. (d) shows invasive adenocarcinoma with tumor hemorrhage. (e) shows
adenocarcinoma with neuroendocrine carcinoma at the extreme left. (f) Tumor cells represent the characteristic features of neuroendocrine
carcinoma with smaller salt and pepper nuclei. (g) shows high-grade adenocarcinoma with giant tumor cells. (h) shows the tumor section with
poorly differentiated carcinoma. (i) presents the tumor section showing the lymphoma pattern.
Figure 6. Schematic representation of gastric cancer incidence of
group 3. Group 3 showed the maximum cancer incidence (95%)
percentage with different types of gastric cancer.
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(DLS) and transmission electron microscopy (TEM), where
DLS showed that the size of the targeted diagnostic probe was
in the range of 20−100 nm with a mean size of 45 nm (Figure
7c). There was an increase of 25−30 nm after the conjugation
of transferrin protein on cysteine-capped CdS QDs (Figure
7e−f). FTIR analysis was done in order to confirm the
conjugation of transferrin on cysteine-capped CdS QDs for the
preparation of the diagnostic probe. The FTIR spectrum of
cysteine-capped CdS QDs (Figure 8a) showed the disappear-
ance of the SH peak (2549.7 cm−1) that is utilized in the
covalent attachment of cysteine sulfur with CdS sulfur with the
introduction of new cysteine associated peaks: the most
important one was seen at 3447.36 cm−1, which represented
the N−H stretching of primary and secondary amines. The
mild peaks of the N−H bending of amines were seen in the
area defined by 1580−16 cm−1. The carboxylic group CO
stretching was seen at 1650.76 cm−1 and C−O stretching was
observed at 1005.19 cm−1. Furthermore, attachment of
transferrin protein was confirmed due to the alteration in the
existing peak positions, intensities, and the introduction of new
peaks (Figure 8b). Fluorescence of nanocomposites was
observed by fluorescence microscopy and excitation and
emission spectroscopy. Microscopy observation confirmed
the sharp green fluorescence of nanocomposites under a blue
Figure 7. Schematic model presentation and characterization of the CdS QD-transferrin-targeted diagnostic probe. Figure (a) shows the schematic
model of a cysteine-capped CdS QD and (b) shows the model of the targeted diagnostic probe. (c) DLS analysis shows that nanocomposites are in
the size range of 20−100 nm with a mean size of 45 nm. (d) shows the fluorescence microscopy observation in the top right corner and excitation/
emission spectra at 364.6 nm/366.1 nm. (e) Micrograph of cysteine-capped CdS QDs shows uniform, monodispersed, stable, and spherical
nanoparticles of mean size 7 nm. (f) Micrograph shows that after conjugation of protein to cysteine-capped CdS QDs, the size of nanocomposites
increased to 35 nm.
Figure 8. FTIR analysis. (a) FTIR spectrum of cysteine-capped CdS QDs shows the stretching and bending peaks of cysteine on the spine
structure of the CdS QD. (b) FTIR spectrum of the diagnostic probe presents the successful conjugation of protein on the nanocarriers with
alteration in the old peak position and introduction of new peaks.
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excitation filter. Excitation and emission spectra showed
maximum excitation at 364 nm and maximum emission at
366 nm (Figure 7d).
2.5. Transferrin Receptor Expression Studies by the
Diagnostic Probe. Gastric cancer/tumors tissues of all the
groups were characterized for the expression of transferrin
receptors. Tissues from infected mice were incubated in vitro
with CdS-conjugated antitransferrin antibodies in order to
confirm increased transferrin expression. Relative transferrin
receptor expression of three groups and control is shown in
Figure 9. Control mouse gastric tissue showed only limited
background fluorescence while tissues from groups 1, 2, and 3
demonstrated fluorescence with many-fold enhanced intensity.
Among the three groups, group 3 showed maximum
fluorescence intensity that confirmed greater expression of
transferrin receptors on gastric tissue of mice with maximum
cancer incidence rates after exposing to H. pylori + MNU +
high dietary salt NaCl for cancer induction. Results show that
the incidence of cancer in group 3 was almost 100% This
confirms that the transferrin receptor expression was greater in
group 3 due to the severity and later stages of cancer. The mice
of this group can be selected for targeted drug delivery
experiments using transferrin as a targeting site.
These results are in line with the literature that reports
tumor progression has high correlation with the increased
expression of the transferrin receptor. Therefore, it could make
for an attractive way to target cancer cells for drug delivery.11
Researchers synthesized the paclitaxel-loaded PLGA nano-
particles and conjugated them with transferrin to target human
prostate cancer cells PC3. These results indicated the
successful regression of tumor cancer cells in nude mice
(Sahoo et al.32). Another study found that the targeted drug
delivery to lung cancer cells by cationic polymer branched
polyethyleneamine (bPEI) conjugated with the transferrin
receptor-binding HAIYPRH peptide (HAI peptide). It
provided a successful way of an efficient delivery of siRNA
into TfR-overexpressing lung cancer cells. This targeted
delivery resulted in efficient GAPDH gene knockdown.33
Another successful lung transferrin receptor-targeted strategy
was reported by Guo et al. with transferrin-conjugated lipid-
coated NPs (TFLP).34,35
2.6. Blood Assays (LFT and RFT). Liver and renal
functional tests were also conducted in order to check the
effect of different induction methods on these organs as shown
in Figure 10. In liver function test (LFT) analysis of group 1, a
minor elevation in aspartate aminotransferase (AST) and high
increase in alkaline phosphatase (ALP) concentration were
observed along with the lower level of albumin, while group 2
showed higher levels of AST and ALT after 6 months and a
Figure 9. Transferrin receptor expression analysis on cancer-induced
mice gastric tissue of all groups in comparison to the control CdS
QD-conjugated antitransferrin binding to control gastric tissue and to
gastric cancer/tumor tissues after tissue incubation with transferrin
shows enhanced receptor expression in cancerous mice. (a) Control
mice show background fluorescence, (b) transferrin receptor
expression on group 1 mouse gastric tissue, (c) mice of group 2
show greater expression of the transferrin receptor but less than
groups 1 and 3. (d) shows transferrin expression after 6 months of
cancer-induction treatment in group 3 mouse gastric tissue. Group 3
mouse stomach tissues show the maximum expression of the
transferrin receptor, many-fold enhanced than the normal tissue
(e,f). The tumor section of group 3 also shows the many-fold
enhanced expression of the transferrin receptor as shown in figures
(g,h).
Figure 10. Statistical comparison of LFT and RFT of control and
groups 1, 2, and 3 mice. Comparison of parameters of the liver profile
shows higher levels of AST and ALP as compared to control and
lower levels of albumin. Cancer-induced mice show higher urea levels
as compared to control.
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little higher level of these two enzymes after 12 months as
compared to the control. In group 3, a higher level of AST and
ALP concentration was observed along with lower levels of
albumin. In renal function test (RFT) analysis, a higher level of
urea with no effect on the creatinine level was observed in all
groups (Figure 10).
3. CONCLUSIONS
Transferrin receptor expression was checked on gastric cancer/
tumor tissues in relation to normal gastric tissues. Chemical
treatment for cancer induction after H. pylori infection showed
increased cancer incidence and increased transferrin receptor
expression. This study describes a complete strategy for the
development of a gastric cancer model in mouse and also
confirmed the enhanced transferrin receptor expression on
gastric cancer tissue. Transferrin receptors can be used as a site
for targeted drug delivery to gastric and colon cancer. Studies
are underway to target these receptors in order to find the best
therapeutic strategy against gastric cancer.
4. EXPERIMENTAL METHODS
4.1. Model Organisms and the Inducing Agents.
BALB/c mice were used to develop models of gastric cancer by
three methods. All animal studies were approved by the
Animal Ethics Committee of the faculty of Life Sciences
(Approval Diary Number D/3363-ACAD), University of the
Punjab, Lahore, Pakistan. Methyl nitrosourea (MNU), pure
food salt (NaCl), and the bacterial species H. pylori were used
for cancer induction. H. pylori was isolated from human
gastroendoscopy samples. It was characterized through 16S
rRNA sequencing. MNU solution was prepared in sterilized
tap water. H. pylori was cultured in brain heart infusion
medium (BHI), and the culture was screened for CagA toxin,
the positive culture for which was mixed and cultivated in BHI
medium for 48 h under microaerophilic conditions at 37 °C
and was used to induce cancer in mice. All the reagents were
purchased from Sigma-Aldrich, UK.
4.2. Experimental Schedule. Animals from groups 1, 2,
and 3 were killed after 6 months and 12 months from the
starting time of induction. Control mice comprised males (n =
5) and females (n = 5) of 4−5 weeks old for each group. Males
and females were kept in separate cages and fed on screened
controlled diet and sterilized distilled water. Figure 11 shows
the flowchart presentation of the conducted experiments to
develop the gastric cancer mouse model.
4.2.1. Group 1: MNU and NaCl-Induced Cancer. Group 1
contained four-week-old 25 male and 25 female mice. They
were divided into two subgroups where the first group
contained 20 mice (10 males/10 females). They were killed
after 6 months, and the other group 30 mice (15 males/15
females) were killed after 12 months. During their life, mice
were fed controlled diet and cancer was induced with MNU
and NaCl; 250 mg of MNU was dissolved in 500 mL of
sterilized tap water and 30% w/v NaCl was added.
Supplemented water was used for the first 3 weeks of the
treatment for cancer induction in light-shielded bottles to
prevent photolysis. MNU solution was prepared fresh twice a
week to replace the old solution. After 3 weeks, water was
supplemented with MNU only and used for the rest of the
period of induction. The animal weight was monitored
throughout this period.
4.2.2. Group 2: H. pylori-Induced Cancer. Mice of group 2
were subdivided into two subgroups: 25 mice (10 males/15
females) were killed after 6 months, and 20 mice (10 males/10
females) were dissected after 12 months. H. pylori inoculation
was used for cancer induction in group 2 mice. One hundred
and twenty microliters of H. pylori suspension in BHI
containing 1 × 109 colony forming units (CFU)/mL were
inoculated through orogastric gavages (intragastric tubes) once
a day and thrice in the first week (Figure 12a). All mice were
kept on an overnight fasting before inoculation with H. pylori
and observed for half an hour after inoculation with orogastric
gavages. After six inoculations with H. pylori, mice were fed
screened pellet diet and filter sterilized tap water for the rest of
their lives. Infected mice were housed in isolation to prevent
the spread of infection among other groups. The animal weight
was recorded throughout the period of treatment.
4.2.3. Group 3: Cancer Induction by Combination of Salts
and H. pylori Inoculation. Mice of group 3 were also
subdivided into two subgroups: 30 mice (15 males/15
Figure 11. Flowchart of the methodology to develop the gastric
cancer mouse model.
Figure 12. Oral dose administration and stomach washing; (a) shows
oral dose (PO) administration to mouse through oral gavages and (b)
shows the washing of the mouse stomach with saline solution.
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females) were killed after 6 months, and 30 mice (15 males/15
females) were dissected after 12 months. Mice of group 3 were
treated in the same pattern as group 1 except inoculation with
H. pylori (1 × 109 colony forming units (CFU)/mL) was made
into mice stomach through orogastric gavages thrice a week.
4.3. Mice Dissection and Sample Collection. At the
time of dissection, the body weight of all mice was recorded.
Before gastrectomy, blood from mice was collected in a vial
and processed for serum isolation. Serum was stored at −20
°C. After dissection of mice, the stomach was removed and
washed with 0.85% NaCl solution with a syringe (Figure 12b).
The stomach was incised along the greater curvature and the
gross anatomy of gastric tissue was examined. The stomach
was fixed in lysine-periodate-paraformaldehyde (PLP) fixative
for histopathological studies.
4.4. Histopathological Studies. PLP-fixed tissues were
dehydrated in an ascending order of ethanol (50, 70, 80, 90,
and 100%) concentration for 6 h to overnight at each step. The
fixed tissue was filtered with ethanol:xylene (1:1 ratio) and
then with 100% xylene. Tissues were embedded in a paraffin
block under the standard protocol of AMBR lab36 and
incubated at 50 °C for 3 h. Paraffin-embedded tissues were
mounted on the specimen disk of a microtome and 8 μm
sections were cut. The sections were placed on albumin-coated
slides and processed for hematoxylin and eosin (H&E)
staining to study the tissue under a microscope.
Tissue sections were rehydrated in a descending order of
ethanol (100, 90, 80, and 70%) concentration and stained with
hematoxylin stain for 8 min. Tissues were washed gently in
running tap water and were differentiated with 1% acid alcohol
(1% HCl in 70% ethanol), followed by staining with eosin, and
a final wash to remove the unbound stain. Tissues were
dehydrated again in an ascending order of alcohol and washed
off with xylene. Tissue sections were mounted with a mounting
medium and observed in a bright field microscope (Olympus
BX51).37
4.5. Targeted Diagnostic Probe Preparation. Cysteine-
capped cadmium sulfide QDs were synthesized in the presence
of taurine (antioxidant), as described in the previous study.
Transferrin was conjugated with cysteine-capped CdS QDs by
the carbodiimide method and used as a cancer-targeting probe.
Briefly, 0.01 g of nanocarriers (CdS QDs in 1 mL of deionized
water, pH:8) was mixed with 1 mL of EDC (20 mg mL−1 of
deionized water) and pH 6.4 was adjusted with 1 M HCl. After
the incubation of 30 min with continuous shaking, 1 mL of
carbodiimide (10 mg mL−1 of deionized water) was added
again with 100 μg of purified transferrin. The reaction mixture
was incubated in the dark for further 2 h at 37 °C with
continuous shaking at 100 rpm. After incubation, modified
QDs were isolated by centrifugation at 14000g for 10 min at 4
°C and washed twice with PBS. The washed QDs were
suspended in 1× TBS buffer for further use and stored at −20
°C.
4.6. Characterization of the Targeted Probe. Samples
were prepared according to the given instructions of the
respective instrumental manual for the characterization of
synthesized cysteine-capped CdS. All the solutions were
degassed under vacuum before proceeding for further
characterization using different techniques. Excitation and
emission spectra were obtained on a fluorescence spectropho-
tometer (PerkinElmer fluorescence spectrophotometer, LS45)
by exciting in the range of 359−364 nm, and the maximum
emission intensity and wavelength were recorded. Fluores-
cence of bare CdS and Cys-CdS QDs was also observed under
different filters of a fluorescence microscope (Olympus BX51);
UV (excitation 350 nm with blue emission 450 nm), blue
(excitation 450 nm with green emission 550 nm), and green
filters of a fluorescence microscope (excitation 550 nm with
deep red emission 690 nm). Surface chemistry of cysteine-
capped CdS and transferrin conjugation were studied by FTIR
spectroscopy (FTIR spectrometer, Agilent Technology Cary
630). The size and shape were studied by TEM (JEOL JEM-
1010) and a DLS analyzer (HORIBA Scientific, nanoPartica
SZ-100) under standard conditions.
4.7. Transferrin Receptor Studies. Dissected stomachs
from all mouse group were fixed in a PLP fixative and studied
for the transferrin expression. Tissues were dehydrated in a
sucrose gradient and embedded in the OCT compound.
Sections of 6−7 μm were cut on a cryostat and placed on
albumin-coated slides and blocked with 5% skimmed milk.
Sections were incubated with modified QDs for 1 h in a
humidified chamber at 37 °C and washed with 1× TBS buffer.
Tissue sections were observed under a blue excitation filter
through a fluorescence microscope.
4.8. Serological Studies. Stored mouse sera were thawed
and analyzed by using a commercial kit HumaLyzer for liver
and renal function tests within 2 days. ALP, AST, alanine
aminotransferase (AAT), bilirubin, albumin, and total proteins
were the parameters in LFTs, whereas creatinine and urea were
determined in RFTs.
4.9. Statistical Analysis. Data were analyzed by one way
analysis of variance and presented as a mean with standard
deviation. SPSS version 26 was used for analysis including
mean ± SD and result significance was declared at p < 0.05. A
paired t-test was also applied to check the significance between
groups at specific conditions and unpaired to check
significance of values within groups at two different times.
OriginPro 8 was used for plotting graphs.
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